Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Hepatocellular 18Liver Neoplasms 9Colorectal Neoplasms 6Cholangiocarcinoma 4Rupture, Spontaneous 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Colonic Neoplasms 2Tissue Adhesions 1Sarcopenia 1Postoperative Complications 1Neoplasms 1Long-term Effects of Cancer Treatment 1Liver Surgery 1Hemangioma 1Focal Nodular Hyperplasia 1Conversion Disorder 1Colorectal Cancer Metastatic 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Hepatectomy × Clear all
NCT01234701 2012-05-28

MRevaluation

University of Zurich

Completed
108 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡